Platelet Function analysis using Multiple Electrode Aggregometry (Multiplate )



Similar documents
Multiplate platelet function analysis - application and interpretation

Screening Tests of Platelet Function: Update on their appropriate uses for diagnostic testing

510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY

510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY DEVICE AND INSTRUMENT TEMPLATE

Predictive power. Multiplate analyzer

Annals of West University of Timisoara

Instructions for Use

Update on Antiplatelets and anticoagulants. Outlines. Antiplatelets and Anticoagulants 1/23/2013. Timir Paul, MD, PhD

ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY. Dr. Mahesh Vakamudi. Professor and Head

L'aspirina è diventata obsoleta nell'era dei nuovi inbitori P2Y12? Leonardo Bolognese MD, FESC, FACC Cardiovascular Department, Arezzo, Italy ISO 9001

Platelet Aggregation Testing in Platelet-Rich Plasma Description of Procedures With the Aim to Develop Standards in the Field

EVALUATION OF NOVEL LABORATORY METHODS USING WHOLE BLOOD TESTING IN DIFFERENT DISTURBANCES OF HAEMOSTASIS. Ph.D. thesis. Author: Dr.

Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty

Use of Antithrombotic Agents In The Presence Of Neuraxial Anesthesia

Dual Antiplatelet Therapy. Stephen Monroe, MD FACC Chattanooga Heart Institute

Managing Anticoagulants, Antiplatelets, and NSAIDS in the Interventional Radiology Setting. Amy Huggins, BSN, RN

GUIDELINES IN ANTIPLATELET AND ANTICOAGULATION RX IN CARDIAC SURGERY

Bleeding disorders or haemorrhagic diatheses are a group of disorders characterised by defective haemostasis with abnormal bleeding.

Antithromboticthrombotic Monitoring

Management of Patients on Anticoagulants. Haemostasis. Coagulation cascade. Cell-based model 19/11/2013

A Patient s Guide to Primary and Secondary Prevention of Cardiovascular Disease Using Blood-Thinning (Anticoagulant) Drugs

Guidelines for the Laboratory Investigation of Heritable Disorders of Platelet Function

What we all Needs to Know about New and Old Anticoagulant and Antiplatelet Drugs. None related to this presentation 11/22/2012

Duration of Dual Antiplatelet Therapy After Coronary Stenting

Perioperative management of Dual Antiplatelet therapy post drug eluting stent-changing time

MultiplateT Analyzer für die Thrombozytenfunktionstestung. Literaturübersicht

NEW ANTIPLATELET AGENTS: An ideal platelet agent would have the following characteristics: 1. quick onset 2. reversible 3. benefit to patients 4.

Platelet Transmission Electron Microscopy and Flow Cytometry 11/15/2015

Review of Newer Antiplatelets, Antithrombotics and Reversal

Antiplatelet and Antithrombotics From clinical trials to guidelines

LAMC Reversal Agent Guideline for Anticoagulants Time to resolution of hemostasis (hrs) Therapeutic Options

Warfarin and Novel Anti-Coagulants: Management Before and After the Cath Lab

Note: Page numbers in italics indicate figures. Page numbers followed by a t indicate tables.

Guidelines for the Management of Anticoagulant and Anti-Platelet Agent Associated Bleeding Complications in Adults

INR = (patient PT/mean normal PT) ISI.

MCHENRY WESTERN LAKE COUNTY EMS SYSTEM OPTIONAL CE ADVANCED LEVEL (EMTP, PHRN, ECRN) August Anticoagulants

Antikoagulation und antithrombotische Therapie bei Herzerkrankungen

Financial Disclosures. Learning Objectives 05/06/2015. None

Learning Objectives. Qualitative and Quantitative Platelet Disorders. Platelet Signaling. Platelet vs. Coagulation Bleeding.

EMMC Guide on Management of Anticoagulant and Anti-Platelet Agent Associated Bleeding Complications in Adults. February, 2013

Inc. Wuhan. Quantity Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4 Standard (liquid) 2

Whole Blood Flow Cytometry

Clinical Guideline N/A. November 2013

The Society of Thoracic Surgeons (STS) Workforce on

Platelet Review July Thomas S. Kickler M.D. Johns Hopkins University School of Medicine

An#- Coagulant An#- Thrombo#c An#- Platelet Drugs

Schlüsselwörter Thrombozytenfunktion, klinische Anwendung, Antithrombotika, Blutungsrisiko

Cyclooxygenase and NSAIDs

New anticoagulants: Monitoring or not Monitoring? Not Monitoring

Devang M. Desai, MD, FACC, FSCAI Chief of Interventional Cardiology Director of Cardiac Catheterization Lab St. Mary s Hospital and Regional Medical

Dabigatran (Pradaxa) Guidelines

Antiplatelet drugs, coronary stents, and non-cardiac surgery

Thrombosis and Bleeding

Platelet storage pool disease case discussions. Tzu-Fei Wang The Hemostasis and Thrombosis Center The Ohio State University

Session 3 Topics. Argatroban. Argatroban. Drug Use and Adverse Effects. Laboratory Monitoring of Anticoagulant Therapy

East Kent Prescribing Group

Impact of new (direct) oral anticoagulants in patient blood management

Blood Management Today Incorporating TEG

Canine creatine kinase MB isoenzyme (CK-MB)ELISA Kit

New Approaches to, and Indications for, Antiplatelet Therapy

Critical Bleeding Reversal Protocol

Lupus anticoagulant Pocket card

Como mejorar el manejo médico de los diabéticos con SCA

Dorset Medicines Advisory Group

PLATELETS: OVERVIEW. J. Kelton, M.D. May 3 rd, 2003

USE AND INTERPRETATION OF LABORATORY COAGULATION TESTS IN PATIENTS WHO ARE RECEIVING A NEW ORAL ANTICOAGULANT (DABIGATRAN, RIVAROXABAN, APIXABAN)

NHS FORTH VALLEY Rivaroxaban for Stroke Prevention in Atrial Fibrillation

6 H2O + 6 CO 2 (g) + energy

Medications in Stroke Rehabilitation THE GOALS OF PRESENTATION STROKE STATISTICS 9/9/2014

Hemostasis analyzer system

What You Should NOAC About the New Anticoagulants. Dr Calum Young Cardiologist

Cilostazol versus Clopidogrel after Coronary Stenting

Getting smart about dyspnea and life saving drug therapy in ACS patients. Kobi George Kaplan Medical Center Rehovot

Rational for secondary prophylaxis in VWD

PFA-100 Platelet Function Analyzer In vitro method for platelet function testing

Rat creatine kinase MM isoenzyme (CK-MM) ELISA Kit

THE NEW GENERATION OF ORAL ANTICOAGULANTS

New Oral Anticoagulants

DUAL ANTIPLATELET THERAPY. Dr Robert S Mvungi, MD(Dar), Mmed (Wits) FCP(SA), Cert.Cardio(SA) Phy Tanzania Cardiac Society Dar es Salaam Tanzania

ABOUT XARELTO CLINICAL STUDIES

Point-of-care testing Thrombelastography and platelet transfusion

Hemostasis. Bleeding and Clotting. Hemostasis. Platelet Function. Platelet Degranulation Products

Rat creatine kinase MM isoenzyme (CK-MM) ELISA Kit

Laboratory Evaluation of Hemostasis

New oral anticoagulants and antiplatelets: Where do they fit? Meredith Hollinger, PharmD BCPS

WOEST TRIAL- NO ASPIRIN IN STENTED PATIENTS REQUIRING ANTICOAGULATION. Van Crisco, MD, FACC, FSCAI First Coast

SCRN Medication Review. Susan M. Gaunt MS APRN ACNS-BC CCRN CNRN Gwinnett Medical Center

Management of the new antiplatelets and anticoagulants

Transcription:

Platelet Function analysis using Multiple Electrode Aggregometry (Multiplate )

Multiplate platelet function analysis in whole blood based on impedance aggregometry

Multiplate instrument 5 channels for parallel tests easy to use Windows XP based software automatic analysis and documentation duplicate sensor for internal quality control electronic pipetting

applications Multiplate is already one of the most widely used platelet function tests

Performing the test put the test cell into the measuring position attach the sensor cable pipette 300 µl of saline + 300 µl of blood* allow 3 minutes for warming and equilibration add the activator after 6 minutes: print the results discard the test cell * usually hirudin or heparin blood

Multiplate reagents comprehensive line of dedicated reagents

Multiplate tests 1/2 activation inhibition 1 release of arachidonic acid COLtest Collagen TXA 2 ASPItest Arachidonic Acid Aspirin NSAID TXA 2 ArA 1 COX TRAPtest TRAP ADPtest ADP resting platelet Clopidogrel Prasugrel Cangrelor PGE1 ADPtest HS (ADP + PGE1) platelet activation GpIIb /IIIa receptor exposure degranulation GpIIb/IIIa antagonists: Reopro (abciximab) Aggrastat (Tirofiban) Integrillin (Eptifibatid) activated platelet

Multiplate tests 2/2 test activation sensitivity not sensitive for ASPItest arachidonic acid: is converted to TXA2 by platelet-own cyclooxygenase aspirin, IIb/IIIa antagonists clopidogrel, vwf ADPtest ADP: binds onto platelet ADP receptors clopidogrel, IIb/IIIa antagonists aspirin, vwf ADPtest HS ADP + prostaglandin E1 (Prostaglandin is a natural inhibitor and enhances the sensitivity of the assay for clopidogrel) clopidogrel, IIb/IIIa antagonists aspirin, vwf TRAPtest TRAP-6 (thrombin receptor activating peptide): TRAP-6 is a potent agonist which mimicks the platelet-activating action of thrombin IIb/IIIa antagonists vwf, aspirin, clopidogrel (weak effect on TRAPtest) COLtest collagen: collagen activates platelet and triggers a release of arachidonic acid from the platelet membrane, which is converted to TXA2 by the Cyclooxygenase aspirin, IIb/IIIa antagonists clopidogrel, vwf RISTOtest Ristocetin: vwf dependent platelet activation via the GpIb receptor Bernard-Soulier syndrome, severe vwd, aspirin mild vwd

multiple electrode aggregometry = MEA - one Multiplate test cell incorporates two independent sensor units. - the increase of impedance due to the attachment of platelets to the electrodes is detected for each sensor unit separately and transformed to arbitrary aggregation units (AU) that are plotted against time. - the duplicate sensors serve as an internal control test 1+2 - during each measurement Pearson s correlation coefficient of single measurements of the curves assessed by the two electrode pairs and the difference of the two AUCs is calculated. The result is flagged if the values are outside of the acceptance range (correlation coefficient <0.98, difference to the mean curve >20%). D. Sibbing et al, Thromb Haemost. 2008 Jan;99(1):121-6.

blood sample for Multiplate analysis - citrated blood is the typical sample anticoagulant used for platelet function analysis - citrate complexes approx. 98% of the free calcium in the sample - however calcium is an important second messenger of platelet activation - therefore citrate has the potential to disturb platelet function tests - for Multiplate analysis a tight attachment of platelets onto the impedance sensor is mandatory, which enhances the effect of calcium depletion on this method - therefore the analysis of blood anticoagulated by hirudin or heparin is recommended - hirudin blood collection tubes are commercially available from the manufacturer of Multiplate Since hirudin and other direct acting thrombin inhibitors do not reduce the concentration of divalent cations in plasma, these can be considered to provide a more physiological environment than the use of sodium citrate. On this basis, we would agree with the recommendation by Dynabyte that the use of hirudin or another direct acting thrombin inhibitor is preferable for measurements of platelet aggregation performed by MEA (multiple eletrode aggregometry = Multiplate). A. Johnson, Thromb Haemost. 2008 Jun;99(6):1127-9.

Why study platelet function in whole blood rather than in PRP? In PRP not all platelets may be present, the most active platelets and larger platelets may have been lost during centrifugation In PRP platelets are studied in isolation which is NOT their natural situation In whole blood other blood cells are also present - erythrocytes (a potential source of ADP and ATP and a means of removing adenosine) and leucocytes which also influence platelet aggregation. S. Heptinstal et al

examples TRAPtest ASPItest ADPtest no platelet inhibition 113 U 102 U 89 U 17 U 100 mg aspirin qd 139 U 134 U 75 mg clopidogrel qd 98 U 89 U 31 U 100 mg aspirin + 75 mg clopidogrel qd 88 U 8 U 17 U tirofiban (Aggrastat i.v.) 7 U 3 U 3 U

A.B. *1971 very weak aggregation in all tests due to Glanzman Thrombasthenia

near-patient application of Multiplate university clinic Frankurt / Main Hannover medical school Essen university clinic

Multiplate in interventional cardiology / neuroradiology

2 patients before and after aggrastat loading dose Aggrastat Aggrastat case report by Dr. med. Stefanie Müller-Schunk, Neuroradiologie, Klinikum der Universität München

2 patients before and after aspirin 500 mg i.v. aspirin 500 mg i.v. aspirin 500 mg i.v. 50 min after aspirin application case reports by Dr. med. Stefanie Müller-Schunk, Neuroradiologie, Klinikum der Universität München

increase of clopidogrel dose Nonresponse Response clopidogrel 75mg clopidogrel 2x75mg

change from clopidogrel to prasugrel Stent thrombosis AU AU 0 6 min Clopidogrel 150mg/d F. Krötz, Kardiologie, Klinikum der Universität München 0 6 min Prasugrel 10mg/d

Platelet Function Analysis Market simple whole-bloodbased 1-2 different tests available single chanel Multiplate complicated low standardisation used in research and reference labs cartridge-based platelet function tests easy-to-use multi-channel several tests available open system optical aggregometry flow cytometry

Summary Multiplate is one of the newer platelet function tests. The system has a high sensitivity for anti-platelet drugs (Aspirin, Clopidogrel, Prasugrel, IIbIIIa antagonists). It is widely used in laboratory and near-patient settings. Studies have shown a good predictivity towards thromboembolism in platelet non-responsiveness (10 fold enhanced risk for stent thrombosis in a study including 1608 patients following PCI). Studies have shown a predictivity for transfusion requirements during / after cardiac surgery. Further applications include the assessment of platelet disorders, drug interactions and animal models.